Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1

Conditions

Prostatic Neoplasms 21Urinary Bladder Neoplasms 3Breast Neoplasms 3Neoplasms 2Kidney Neoplasms 2Vulvar Neoplasms 1Uterine Cervical Neoplasms 1Testicular Neoplasms 1Stomach Neoplasms 1Stage I Mixed Cell Type Kidney Wilms Tumor 1Skin Neoplasms 1Sezary Syndrome 1Rectal Neoplasms 1Prostate Adenocarcinoma 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Precancerous Conditions 1Pdgfra-Associated Chronic Eosinophilic Leukemia 1Pancreatic Neoplasms 1Pain 1Ovarian Neoplasms 1Obesity 1Neuroblastoma 1Myeloproliferative Disorders 1Mycosis Fungoides 1Multiple Myeloma 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1

Interventions

durvalumab 1Observation 1Gemcitabine 1Cisplatin 1Chemoradiotherapy 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Gallbladder Cancer Unresectable × Observation × Genitourinary × Clear all
NCT05493956 2022-09-09

RACE-GB

Sanjay Gandhi Postgraduate Institute of Medical Sciences

Phase NA Unknown
120 enrolled
GastrointestinalGenitourinary

Gallbladder Cancer Unresectable

Data powered by HemOnc (CC BY 4.0) Colophon âš¡